SCYL2 and lung carcinoma: The GluProRS interactions with the tRNA-dihydrouridine synthase 2 (DUS2) in lung cancer and with the SCY1-like protein 2 (SCYL2) in gastric cancer drive cell proliferation and have tumorigenic effects [35,36].